In our recent study, we have highlighted the potential of developing reciprocal miR-99b-5p/nuclear mTOR (downregulated/upregulated) as a prognostic biomarker for aggressive AA PCa and other metastatic solid tumors. This evidence concerns the gene MTOR and posterior cortical atrophy.